Загрузка...
In vivo assessment of the drug interaction between sorafenib and paracetamol in rats
PURPOSE: Sorafenib is a multi-targeted tyrosine kinase inhibitor (TKI) used for the treatment of advanced renal cell carcinoma, hepatocellular carcinoma and radioactive iodine resistant thyroid carcinoma. Neoplastic diseases are the cause of pain, which may occur regardless of the stage of the disea...
Сохранить в:
| Опубликовано в: : | Cancer Chemother Pharmacol |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer Berlin Heidelberg
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7305075/ https://ncbi.nlm.nih.gov/pubmed/32394097 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-020-04075-3 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|